Kennedy RD - Search Results

1

PICan: An integromics framework for dynamic cancer biomarker discovery.

McArt DG, Blayney JK, Boyle DP, Irwin GW, Moran M, Hutchinson RA, Bankhead P, Kieran D, Wang Y, Dunne PD, Kennedy RD, Mullan PB, Harkin DP, Catherwood MA, James JA, Salto-Tellez M, Hamilton PW. McArt DG, et al. Among authors: kennedy rd. Mol Oncol. 2015 Jun;9(6):1234-40. doi: 10.1016/j.molonc.2015.02.002. Epub 2015 Mar 4. Mol Oncol. 2015. PMID: 25814194 Free PMC article.

2

BRCA1: mechanisms of inactivation and implications for management of patients.

Kennedy RD, Quinn JE, Johnston PG, Harkin DP. Kennedy RD, et al. Lancet. 2002 Sep 28;360(9338):1007-14. doi: 10.1016/S0140-6736(02)11087-7. Lancet. 2002. PMID: 12383682 Review.

3

Role played by BRCA1 in regulating the cellular response to stress.

Gilmore PM, Quinn JE, Mullan PB, Andrews HN, McCabe N, Carty M, Kennedy RD, Harkin DP. Gilmore PM, et al. Among authors: kennedy rd. Biochem Soc Trans. 2003 Feb;31(Pt 1):257-62. Biochem Soc Trans. 2003. PMID: 12546697 Review.

4

The biology of breast carcinoma.

Kennedy RD, Quinn JE, Mullan PB, Harkin DP. Kennedy RD, et al. Cancer. 2003 Sep 15;98(6):1327-8; author 1328-9. doi: 10.1002/cncr.11591. Cancer. 2003. PMID: 12973860 Free article. No abstract available.

5

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, Harkin DP. Quinn JE, et al. Among authors: kennedy rd. Cancer Res. 2003 Oct 1;63(19):6221-8. Cancer Res. 2003. PMID: 14559807

6

BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3.

Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP. Gilmore PM, et al. Among authors: kennedy rd. Cancer Res. 2004 Jun 15;64(12):4148-54. doi: 10.1158/0008-5472.CAN-03-4080. Cancer Res. 2004. PMID: 15205325

7

The role of BRCA1 in the cellular response to chemotherapy.

Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. Kennedy RD, et al. J Natl Cancer Inst. 2004 Nov 17;96(22):1659-68. doi: 10.1093/jnci/djh312. J Natl Cancer Inst. 2004. PMID: 15547178 Review.

8

The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosis.

Mullan PB, Hosey AM, Buckley NE, Quinn JE, Kennedy RD, Johnston PG, Harkin DP. Mullan PB, et al. Among authors: kennedy rd. Oncogene. 2005 Aug 18;24(35):5492-501. doi: 10.1038/sj.onc.1208698. Oncogene. 2005. PMID: 15940267

9

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. Kennedy RD, et al. Cancer Res. 2005 Nov 15;65(22):10265-72. doi: 10.1158/0008-5472.CAN-05-1841. Cancer Res. 2005. PMID: 16288014

10

BRCA1 and implications for response to chemotherapy in ovarian cancer.

Quinn JE, Carser JE, James CR, Kennedy RD, Harkin DP. Quinn JE, et al. Among authors: kennedy rd. Gynecol Oncol. 2009 Apr;113(1):134-42. doi: 10.1016/j.ygyno.2008.12.015. Epub 2009 Jan 24. Gynecol Oncol. 2009. PMID: 19168207 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page